What medication should be given for a patient with a CIWA‑B score of 28 out of 40?

Management of CIWA-B Score 28/40

For a patient with a CIWA-B score of 28 out of 40, administer benzodiazepines immediately using a symptom-triggered approach, as this represents moderate-to-severe benzodiazepine withdrawal requiring pharmacological intervention.

Understanding the Score

• A CIWA-B score of 28/40 indicates moderate-to-severe withdrawal that requires immediate benzodiazepine treatment 1
• The CIWA-B scale comprises 22 items specifically validated to distinguish benzodiazepine withdrawal from baseline symptoms 1
• Symptom-triggered regimens are as effective as fixed-dose schedules and prevent drug accumulation 2

Immediate Pharmacological Management

First-Line Treatment: Benzodiazepines

Diazepam (preferred for most patients):

• Administer 10-20 mg orally or IV as initial dose 3
• Reassess CIWA-B score every 1-2 hours 4
• Repeat diazepam 10-20 mg if CIWA-B remains >15 3
• Long-acting benzodiazepines like diazepam provide superior protection against seizures and prevent symptom breakthrough 2

Lorazepam (for elderly or hepatic dysfunction):

• Use 2-4 mg orally, IV, or IM as initial dose 5
• Short/intermediate-acting benzodiazepines are safer in patients with liver impairment 2
• Reassess every 1-2 hours and repeat dosing based on CIWA-B score 4

Dosing Strategy

• High-dose front-loading approach with long-acting benzodiazepines reduces physical restraint use and shortens hospital length of stay compared to lower-dose protocols 3
• Continue symptom-triggered dosing until CIWA-B score drops below 8-10 consistently 4, 1
• Typical total diazepam requirements range from 40-150 mg over first 24-48 hours for moderate-to-severe withdrawal 4, 3

Alternative Agent (If Benzodiazepines Contraindicated)

Phenobarbital:

• Administer 260 mg IV loading dose (approximately 3-4 mg/kg) 5
• Phenobarbital is similarly effective to lorazepam for mild-to-moderate withdrawal and may be considered if benzodiazepines are unavailable 5
• However, benzodiazepines remain the gold standard 2

Critical Monitoring Parameters

• Reassess CIWA-B score every 1-2 hours until score <8, then every 4-6 hours 4, 1
• Monitor for respiratory depression, especially with high cumulative benzodiazepine doses 2
• Watch for progression to severe withdrawal complications: seizures, delirium, autonomic instability 2
• Measure vital signs (blood pressure, pulse, temperature) with each CIWA-B assessment 1

Common Pitfalls to Avoid

• Do not use fixed-dose tapering when symptom-triggered approach is feasible—it leads to unnecessary drug accumulation without improved outcomes 2, 4
• Avoid short-acting benzodiazepines as monotherapy (e.g., lorazepam alone) in patients without hepatic dysfunction—long-acting agents provide better seizure prophylaxis 2
• Do not withhold benzodiazepines based solely on concern for dependence—untreated benzodiazepine withdrawal can progress to life-threatening complications including seizures and delirium 2
• Limit benzodiazepine use to 10-14 days maximum to minimize abuse potential, especially in patients with substance use disorders 2
• Do not confuse CIWA-B (benzodiazepine withdrawal) with CIWA-Ar (alcohol withdrawal)—they assess different withdrawal syndromes requiring different management approaches 2, 1

Special Considerations

• If patient has traumatic brain injury, be aware that TBI symptoms overlap with withdrawal symptoms and may artificially elevate CIWA scores; consider antipsychotics (haloperidol) for agitation rather than escalating benzodiazepines 6
• In elderly patients, start with lower doses (diazepam 5-10 mg or lorazepam 1-2 mg) and titrate more cautiously 2
• Ensure adequate hydration and nutritional support during withdrawal treatment 2